Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-22

Clinical Trial Update: Study of Clevidipine Assessing Its Preoperative Antihypertensive Effect in Cardiac Surgery (ESCAPE-1) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating clevidipine as a preoperative antihypertensive in cardiac surgery (ESCAPE-1) has completed. The study is sponsored by The Medicines C…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • clevidipine (clevidipine)

Snippet

Sponsor: The Medicines Company | Conditions: Hypertension | Phase 3 | Status: COMPLETED